Skip to main content
ZLAB
NASDAQ Life Sciences

Officer & Director Du Ying Files Intent to Sell Nearly $1M in Shares, Continuing Recent Pattern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$18.95
Mkt Cap
$2.325B
52W Low
$15.96
52W High
$44.34
52W Position info
19% above low
Off High info
57% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ZLAB sits 19% above its 52-week low of $15.96.

Summary

Zai Lab Officer and Director Du Ying has filed an intent to sell an additional $976,000 in shares, extending a pattern of significant insider selling over the past three months.


Key Events · Ownership and Investor Activity · ZLAB

  • Intent to Sell Shares

    Officer and Director Du Ying filed a Form 144 indicating intent to sell 50,000 American Depositary Shares, valued at approximately $976,000.

  • Continuation of Selling Pattern

    This filing extends a recent pattern of insider selling by Du Ying, who has sold shares totaling over $7 million in gross proceeds over the past three months.

  • Executive Selling

    The filer, Du Ying, holds roles as both an Officer and Director, making this a significant executive transaction.


Analysis · ZLAB · Life Sciences

This Form 144 filing indicates Officer and Director Du Ying's intent to sell an additional $976,000 worth of shares. This follows a series of similar filings by Du Ying, totaling over $7 million in sales over the past three months. The continuous selling by a key executive could be interpreted negatively by the market, suggesting a lack of confidence or a need for liquidity, especially given the company's recent mixed financial results (Q1 revenue decrease, but reduced operating cash burn).

How filings like this one have moved

In the 30 days to Oct 5, 2026, 36.9% of the 964 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.65%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ZLAB was trading at $18.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $15.96 to $44.34. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ZLAB - Latest Insights

ZLAB
Aug 06, 2026, 6:40 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $18.64
Real-time Price: $24.23 info
Change: +$5.59 (+30%) info
Market Cap: $2.843B info
ZLAB
Aug 06, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.64
Real-time Price: $24.23 info
Change: +$5.59 (+30%) info
Market Cap: $2.843B info
ZLAB
Jun 17, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.88
Real-time Price: $24.23 info
Change: +$6.35 (+36%) info
Market Cap: $2.843B info
ZLAB
May 21, 2026, 5:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $19.10
Real-time Price: $24.23 info
Change: +$5.13 (+27%) info
Market Cap: $2.843B info
ZLAB
May 15, 2026, 9:49 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $21.22
Real-time Price: $24.23 info
Change: +$3.02 (+14%) info
Market Cap: $2.843B info